logo
Monthly symptom suffered by millions of women linked to huge increased heart attack and stroke risk - as cases soar in young people

Monthly symptom suffered by millions of women linked to huge increased heart attack and stroke risk - as cases soar in young people

Daily Mail​3 days ago
Millions of women who suffer a severe form of premenstrual syndrome (PMS) are at far greater risk of suffering a potentially deadly stroke, a major study suggests.
While most women will suffer from PMS—which can cause distressing physical and emotional symptoms in the weeks before their period—at some point, about a third can suffer a severe form that can require treatment.
Now, Swedish researchers have found women diagnosed with PMS were overall 10 per cent more likely to suffer from cardiovascular disease than women without a diagnosis.
Breaking down cardiovascular disease by specific health problems, the team found these women had at 27 per cent greater risk of suffering a stroke and 31 per cent of developing a heart arrhythmia.
An arrhythmia is potentially serious problem with how the heart beats—either too slow, too fast or inconsistently—which can contribute to heart attacks.
In the study, experts from the Karolinska Institute in Stockholm examined 22 years of health data from just under 100,000 women who had been diagnosed with PMS.
They compared heart health outcomes like stroke and arrhythmia diagnoses with rates in the general population as well as with the women's sisters who hadn't been diagnosed with PMS.
Writing in the journal Nature Cardiovascular Research, the team said that even when accounting for factors known to increase cardiovascular disease risk—like obesity and smoking status—the link between health problems and PMS remained.
Yihui Yang an expert in environmental medicine and first author of the study said the risk of these cardiovascular problems was particularly high for certain groups of women.
'The increased risk was particularly clear in women who were diagnosed before the age of 25 and in those who had also experienced postnatal depression, a condition that can also be caused by hormonal fluctuations,' she said.
Scientists said that exactly how PMS was causing an increased risk of cardiovascular problems was unclear.
They suggested that the heightened hormonal fluctuations PMS patients experience could disrupt other biological systems that control aspects like blood pressure, increase inflammation, or the conversion of food into energy, as potential factors.
However, the team added this was an area in need of further research.
Estimates of how many women suffer from clinically significant—meaning requiring treatment—PMS vary as different criteria can be used.
Some studies put the prevalence at one in 20 while others estimate it to be 30 per cent, roughly about one in three.
Medics argue that if PMS causes issues that affect a woman's physical, psychological, social and economic wellbeing than this warrants a diagnosis and subsequent support and treatment.
However, British experts estimate that only between one in four and one in two women with clinically significant PMS actually seek help from doctors.
PMS is an umbrella term for a range of physical and mental symptoms that typically occur one to two weeks before a woman's period.
This is what is called the luteal phase of a woman's menstrual cycle and is the period between ovulation—when an egg is released from an ovary—and menstruation—the shedding of the lining of the uterus that causes vaginal bleeding.
Symptoms of PMS include mood swings, depression, irritability, anxiety, sleep problems, bloating and cramping, headaches, breast tenderness, spots, greasy hair and changes in appetite.
Some women experience more of these symptoms than others and the amount and severity of these can change over a course of a woman's life.
Women whose PMS is causing them issues are initially advised by the NHS to take steps like exercising more, doing yoga and meditation and cutting down on smoking and alcohol to help alleviate their symptoms.
If these lifestyle changes don't work women can contact their GP who can advise on further treatment.
This can include cognitive behavioural therapy, hormone-based medications like the contraceptive pill, or antidepressants.
More rarely, women can experience an extremely severe form of PMS known as premenstrual dysphoric disorder (PMDD).
PMDD patients can suffer an extreme physical and mental health problems that can include full-blown psychotic episodes and suicidal feelings.
The condition is thought to affect about 824,000 women in the UK and 4.2 million in the US.
The new study comes as heart attacks and strokes, particularly among young people, are on the rise in the UK.
Experts have blamed factors like factors like rising obesity levels as well as smoking and alcohol consumption for the rise in cardiac emergencies in the young.
There is also some evidence that strokes are on the rise in younger people – with a quarter of strokes in the UK, around 20,000 cases, occurring in people of working age, according to the Stroke Association.
And while stroke cases diagnosed yearly has dropped in older age groups over the last 10 to 20 years, it has doubled in those under 55, according University of Oxford researchers who have a study to try to understand the reasons behind this rise.
Strokes are occur when the blood supply to the brain is cut off, usually by a blood clot in a critical artery.
The medical emergency affects more than 100,000 Britons annually—one every five minutes—claiming 38,000 lives.
Britons are advised to keep in mind the four-letter acronym, FAST (Face, arms, speech, time) for potential stroke symptoms.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A Berlin doctor goes on trial, accused of murdering 15 patients
A Berlin doctor goes on trial, accused of murdering 15 patients

The Independent

time43 minutes ago

  • The Independent

A Berlin doctor goes on trial, accused of murdering 15 patients

A German doctor went on trial in Berlin Monday, accused of murdering 15 of his patients who were under palliative care. The prosecutor's office brought charges against the 40-year-old doctor 'for 15 counts of murder with malice aforethought and other base motives' before a Berlin state court. The prosecutor's office is seeking not only a conviction and a finding of particularly serious guilt, but also a lifetime ban on practicing medicine and subsequent preventive detention. Murder charges carry a maximum sentence of life in prison. If a court establishes that a suspect bears particularly severe guilt, that means he wouldn't be eligible for release after 15 years as is usually the case in Germany. Parallel to the trial, the prosecutor's office is investigating dozens of other suspected cases in separate proceedings. The man, who has only been identified as Johannes M. in line with Germany privacy rules, is also accused of trying to cover up evidence of the murders by starting fires in the victims' homes. He has been in custody since Aug. 6. The doctor was part of a nursing service's end-of-life care team in the German capital and was initially suspected in the deaths of just four patients. That number has crept higher since last summer, and prosecutors now accusing him of the deaths of 15 people between Sept. 22, 2021, and July 24 last year. The victims' ages ranged from 25 to 94. Most died in their own homes. The doctor allegedly administered an anesthetic and a muscle relaxer to the patients without their knowledge or consent. The drug cocktail then allegedly paralyzed the respiratory muscles. Respiratory arrest and death followed within minutes, prosecutors said. The doctor did not agree to an interview with a psychiatric expert ahead of the trial, German news agency dpa reported. The expert will therefore observe the defendant's behavior in court and hear statements from witnesses in order to give an assessment of the man's personality and culpability. So far, it is unclear what the palliative care physician's motive might have been, dpa reported. The victims named in the indictment were all seriously ill, but their deaths were not imminent. The defendant will not make a statement to the court for the time being, his defense lawyer Christoph Stoll said, according to dpa. The court has initially scheduled 35 trial dates for the proceedings until January 28, 2026. According to the court, 13 relatives of the deceased are represented as co-plaintiffs. There are several witnesses for each case, and around 150 people in total could be heard in court, dpa reported. An investigation into further suspected deaths is continuing. A specially established investigation team in the homicide department of the Berlin State Criminal Police Office and the Berlin public prosecutor's office investigated a total of 395 cases. In 95 of these cases, initial suspicion was confirmed and preliminary proceedings were initiated. In five cases, the initial suspicion was not substantiated. In 75 cases, investigations are still ongoing in separate proceedings. Five exhumations are still planned for this separate procedure, prosecutors said. In 2019, a German nurse who murdered 87 patients by deliberately bringing about cardiac arrests was given a life sentence. Earlier this month, German investigators in the northern town of Itzehoe said they were examining the case of a doctor who has been suspected of killing several patients.

Is resident doctors' pay down 20%, and aftermath of Gaza water queue strike
Is resident doctors' pay down 20%, and aftermath of Gaza water queue strike

BBC News

timean hour ago

  • BBC News

Is resident doctors' pay down 20%, and aftermath of Gaza water queue strike

Update: Date: 10:23 BST Title: Are resident doctors right to say their pay is down 20%? Content: Rupert CareyBBC Verify fact-check editor We'll be looking into the claim by the doctors' union – the BMA – for higher pay for resident doctors in England. The government has offered a 5% rise but the BMA says pay – in real terms (so allowing for the impact of inflation) - is down 20% since 2008 and has voted in favour of strike action. There was an interesting discussion involving the BMA on BBC Radio 4's Today programme this morning about how they are getting to that figure and BBC Verify examining it. Update: Date: 10:14 BST Title: Monday's BBC Verify Live Content: Rob CorpBBC Verify Live editor Welcome to the live page where the BBC Verify team shares what it is doing each day. Our team will post their fact-checks, open-source intelligence work and data journalism here. This morning we're across these stories: If you missed it then do check out our most-read story of the weekend - North Korea's Benidorm-style resort welcomes its first Russian tourists - by clicking here.

I realised I'm a ‘Mounjaro lifer' after stopping for 8 weeks – I lost 5st but now my tummy is a ‘bottomless pit' again
I realised I'm a ‘Mounjaro lifer' after stopping for 8 weeks – I lost 5st but now my tummy is a ‘bottomless pit' again

The Sun

timean hour ago

  • The Sun

I realised I'm a ‘Mounjaro lifer' after stopping for 8 weeks – I lost 5st but now my tummy is a ‘bottomless pit' again

A FAT jab user has revealed that after stopping the injections for eight weeks, she has now realised she is a 'Mounjaro lifer.' Laura, who lost five stone in 13 months thanks to Mounjaro, explained that after pausing the injections, her stomach has now returned to being a 'bottomless pit.' 3 3 The brunette beauty, who was diagnosed with bowel cancer at the age of 38, recently stopped injecting herself with the weight loss jabs for two months whilst she undergoes cancer treatment. Prior to the pause, she had been using Mounjaro for over a year, and has now realised: 'I have learned that I am 100% a Mounjaro lifer - I can't do this without Mounjaro.' Posting on social media, the content creator explained that once she finishes cancer treatment, she plans to go back on the fat jabs. When she first started Mounjaro, she weighed 18 stone 5 lbs, but has since managed to slim down to just 13 stone 5 lbs. But after losing 5 stone and coming off of Mounjaro, which is known as the King Kong of jabs, Laura revealed that things have been 'so f*****g hard.' She admitted: 'It has been super, super hard - the food noise has returned fully, the bottomless pit feeling when I eat is there.' As a result of stopping Mounjaro she acknowledged that she can eat 'endlessly.' Laura has plans to get down to her goal weight of 10 stone 7 lbs, but stressed that she'll need Mounjaro to do so, as she continued: 'I 100% now know I will be staying on Mounjaro forever more, it's got to be done, I can't do this forever, there's only so much willpower.' Now, Laura 'can't wait to restart' the fat jabs and plans to start back at 12.5mg. She confessed: 'I'll be starting back at 12.5mg, which in a way, I'm kind of glad for, so maybe it'll give the lower doses a new lease of life, but what I've learned over the eight weeks is 100% I'm a Mounjaro lifer.' Weight Loss Jabs - Pros vs Cons Other Mounjaro 'lifers' react Laura's TikTok clip, which was posted under the username @ itslauraunfiltered, has clearly left many open-mouthed, as it has quickly amassed 79,800 views. Not only this, but it's also amassed 1,757 likes, 220 comments and 162 saves. And it's clear that Laura isn't the only Mounjaro user who has concerns about being a 'lifer', as numerous fat jab users rushed to the comments to share their similar experiences. One person said: 'I am definitely going to be a lifer. I've battled with obesity for 30 years until now. I can't do it without Mounjaro.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Another added: 'I've not been without it and I'm not at my goal yet, but that's what I think in my head that I'll be taking it for life. Because life is so much nicer on Mounjaro, I just don't want to struggle again.' A third commented: 'I will never stop taking this. It would be like giving someone glasses to see them away again!' It has been super, super hard - the food noise has returned fully, the bottomless pit feeling when I eat is there Laura, Mounjaro user Meanwhile, someone else admitted: 'I feel the same way. I really enjoy the routine. I'm excited for jab day. I'm on a really low dose. I can't ever imagine stopping.' Not only this, but another Mounjaro user revealed: 'I'm stopping next week. I'm dreading it. 'I've stopped losing weight over the past two months. I'm quite happy where I am, I'd like to lose another stone…however I can't say I'm not fearful of next week and beyond.' The reality of Mounjaro Although many have boasted about weight loss success since using Mounjaro, last year it was revealed that Scots nurse Susan McGowan, 58, died after taking low-dose injections of Mounjaro over a fortnight. A probe also found that nearly 400 people have gone to hospital after taking weight loss drugs. The common side effects include nausea, vomiting and diarrhoea, which can lead to severe dehydration. What are the other side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections such as Ozempic include: Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting: Can occur, often in conjunction with nausea. Diarrhea: Some people experience gastrointestinal upset. Constipation: Some individuals may also experience constipation. Stomach pain or discomfort: Some people may experience abdominal pain or discomfort. Reduced appetite: This is often a desired effect for people using Ozempic for weight loss. Indigestion: Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin. And if that wasn't bad enough, doctors say they have also seen 'life-threatening complications', including seizures, bowel obstruction and inflammation of the pancreas. Model Lottie Moss, 27, even said she had a seizure after taking high doses of Ozempic. The makers of Mounjaro, Lilly UK, said patient safety is its 'top priority'. Lilly UK stressed: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data. 'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store